EUVIMEDEUVIMED entdecken
Crossref

Neuregulin-1β Mitigates Doxorubicin-Induced Cardiotoxicity via in Cardiac Fibroblasts

Parisa Aghagolzadeh, Lifen Xu, Klinger, Philipp, C Morandi, Lilia Maryse Lépine, Lukas Minder, Pieter‐Jan Guns, Matthias Bosman, Marie‐May Coissieux, Thierry Pedrazzini, Gabriela Kania und 1 weitere

Zurich Open Repository and Archive (University of Zurich) · 21.05.2026

DOI: 10.5167/uzh-435572 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Zurich Open Repository and Archive (University of Zurich), erschienen am 21.05.2026. Verfasst von Parisa Aghagolzadeh und 12 weiteren Autor:innen.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Anthracyclines such as doxorubicin (DOX) are widely used in cancer treatment, but their benefits are offset by dose-related cardiotoxicity. Neuregulin-1β (NRG1) has been studied as a cardioprotective factor, yet its mechanisms during DOX treatment, particularly in the presence of cancer, are not well understood. This study evaluated daily recombinant NRG1 co-administered with DOX in 4T1-tumor-bearing female BALB/c mice. The mice were randomized to saline, DOX (3 mg/kg i.p. on days 0, 3, 6, 9; cumulatively 12 mg/kg) or DOX + NRG1 (20 µg/kg i.p. daily, starting one day before DOX). Body weight and tumor growth were monitored throughout treatment. Cardiac structure and function were assessed by transthoracic echocardiography at baseline and before sacrifice. Mechanistic studies included left ventricular proteomics and single-cell RNA-seq. We also used human 3D cardiac microtissues and 2D primary cardiac fibroblast-enriched cultures under defined experimental conditions, with targeted fibroblast gene perturbations. We found that early DOX exposure induced systolic dysfunction and pathological remodeling, while daily NRG1 preserved the ejection fraction and attenuated structural changes without impairing anti-tumor efficacy. Proteomic analysis identified as one of the most strongly upregulated proteins soon after DOX exposure, an effect that was reversed by NRG1. Notably, has not previously been implicated in anthracycline cardiotoxicity or NRG1-mediated protection. Single-cell RNA sequencing localized expression to cardiac fibroblasts. Mechanistically, we found that modulation was associated with altered processing and fibroblast survival under DOX-induced stress; its suppression by NRG1 was linked to reduced fibroblast apoptosis and a shift toward a pro-survival-associated state. In human cardiac microtissues, NRG1 treatment or fibroblast-specific knockdown accelerated cardiomyocyte contraction dynamics. These changes occurred without an increase in apoptosis and point to a paracrine effect of fibroblasts on cardiomyocyte function. Additionally, scRNA-seq revealed an fibroblast subpopulation associated with early pro-fibrotic activation that expanded after DOX but was reduced by NRG1. Taken together, NRG1 preserved cardiac function during anthracycline treatment while maintaining anti-tumor efficacy. Our data identify fibroblast-associated signaling, particularly through , as a potential contributor to the early protective effects of NRG1. These findings add a new dimension to the understanding of NRG1 cardioprotection and suggest that fibroblast-myocyte interactions may contribute to the early cardiac response to DOX.

Schlagwörter

neuregulin-1βdoxorubicinanthracycline cardiotoxicitycardiac fibroblastscardioprotection4T1 breast cancercardiac remodelingfibroblast apoptosiscardiomyocyte contractioncardiac microtissues

Zitieren

APA

Aghagolzadeh, P., Xu, L., Klinger, Philipp, Morandi, C., Lépine, L. M., Minder, L., Guns, P., Bosman, M., Coissieux, M., Pedrazzini, T., Kania, G., & Brink, M. (2026). Neuregulin-1β Mitigates Doxorubicin-Induced Cardiotoxicity via in Cardiac Fibroblasts. Zurich Open Repository and Archive (University of Zurich). https://doi.org/10.5167/uzh-435572

Vancouver

Aghagolzadeh P, Xu L, Klinger, Philipp, Morandi C, Lépine LM, et al. Neuregulin-1β Mitigates Doxorubicin-Induced Cardiotoxicity via in Cardiac Fibroblasts. Zurich Open Repository and Archive (University of Zurich). 2026. doi:10.5167/uzh-435572

BibTeX
@article{Aghagolzadeh2026,
  author = {Aghagolzadeh, Parisa and Xu, Lifen and Klinger and Philipp and Morandi, C and Lépine, Lilia Maryse and Minder, Lukas and Guns, Pieter‐Jan and Bosman, Matthias and Coissieux, Marie‐May and Pedrazzini, Thierry and Kania, Gabriela and Brink, Marijke},
  title = {Neuregulin-1β Mitigates Doxorubicin-Induced Cardiotoxicity via in Cardiac Fibroblasts},
  journal = {Zurich Open Repository and Archive (University of Zurich)},
  year = {2026},
  doi = {10.5167/uzh-435572}
}
Kostenlos starten →